Kim Min-Gyeong, Choi Yong-Seok, Youn Suk Min, Ko Jae-Hee, Oh Hyun Jun, Lee Jong-Ho, Park Joo-Yong, Choi Sung-Weon
Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Department of Oral and Maxillofacial Surgery, Seoul National University Dental Hospital, Seoul, Korea.
J Korean Assoc Oral Maxillofac Surg. 2022 Aug 31;48(4):192-200. doi: 10.5125/jkaoms.2022.48.4.192.
This study aimed to analyze the treatment outcomes and to evaluate the clinicopathological prognostic factors of oral tongue cancer. Patients and.
We retrospectively analyzed treatment results and prognostic factors in 205 patients with oral tongue squamous cell carcinoma who were admitted to the National Cancer Center, South Korea, between January 2001 and December 2020. The patients were treated with surgery and postoperative, definitive radiotherapy (RT) or chemoradiotherapy (CRT).
Eighteen patients (8.8%) were treated with curative RT or CRT, while the rest (91.2%) were treated with surgery with or without postoperative RT or CRT. The median follow-up period was 30 months (range, 0-234 months). The 5-year overall survival (OS) and 5-year disease-free survival (DFS) were 72% and 63%, respectively. Multivariate analysis revealed that a positive neck nodal status (N1, N2-3) was significantly associated with poorer 5-year OS and DFS, while perineural invasion was associated with poorer 5-year DFS.
Cervical metastasis and perineural invasion are significant prognostic predictors, and combination treatments are necessary for improving OS and DFS in patients with these factors.
本研究旨在分析口腔舌癌的治疗结果并评估其临床病理预后因素。患者与……
我们回顾性分析了2001年1月至2020年12月期间收治于韩国国立癌症中心的205例口腔舌鳞状细胞癌患者的治疗结果及预后因素。患者接受了手术及术后根治性放疗(RT)或放化疗(CRT)。
18例患者(8.8%)接受了根治性RT或CRT治疗,其余患者(91.2%)接受了手术治疗,部分患者术后接受了RT或CRT。中位随访期为30个月(范围:0 - 234个月)。5年总生存率(OS)和5年无病生存率(DFS)分别为72%和63%。多因素分析显示,颈部淋巴结阳性状态(N1、N2 - 3)与较差的5年OS和DFS显著相关,而神经侵犯与较差的5年DFS相关。
颈部转移和神经侵犯是重要的预后预测因素,对于有这些因素的患者,联合治疗对于改善OS和DFS是必要的。